10x Genomics (TXG) Share-based Compensation (2018 - 2026)

10x Genomics has disclosed Share-based Compensation across 9 years of filings, most recently posting $25.6 million for Q2 2026.

• In Q2 2026, Share-based Compensation fell 7.05% year-over-year to $25.6 million; the TTM figure through Jun 2026 stood at $98.7 million (down 20.86% YoY), while the FY2025 annual figure was $109.1 million, down 22.47% from the prior year.
• Share-based Compensation came in at $25.6 million for Q2 2026 at 10x Genomics, up from $22.6 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $45.7 million in Q2 2023 to a low of $22.6 million in Q1 2026.
• Average Share-based Compensation over 5 years is $33.4 million, with a median of $33.6 million recorded in 2022.
• Year-over-year, Share-based Compensation soared 61.63% in 2023 and slipped 28.4% in 2025.
• Over 5 years, Share-based Compensation stood at $41.0 million in 2022, then declined by 5.02% to $38.9 million in 2023, then declined by 16.39% to $32.5 million in 2024, then slipped by 22.5% to $25.2 million in 2025, then advanced by 1.57% to $25.6 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $25.6 million in Q2 2026, $22.6 million in Q1 2026, and $25.2 million in Q4 2025.